No association between occupational exposure to ELF magnetic field and urinary 6-sulfatoximelatonin in workers

Bioelectromagnetics

Volumn 27, Issue 8, 2006, Pages 667-673

  Gobba, Fabriziomaria ^a   Bravo, Giulia ^a   Scaringi, Meri ^a   Roccatto, Luigi ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

ELF magnetic fields; Humans; Melatonin secretion; Personal dosimetry

Indexed keywords

BODY FLUIDS; ELECTROMAGNETIC FIELD EFFECTS; HORMONES; MULTIVARIANT ANALYSIS; PHYSIOLOGY;

ADVERSE EFFECT; ELF MAGNETIC FIELDS; EXTREMELY LOW FREQUENCY MAGNETIC FIELDS; FIELD EXPOSURE; HUMAN; MELATONIN SECRETION; OCCUPATIONAL EXPOSURE; PERSONAL DOSIMETRY; WORK SHIFTS; WORKERS';

EXPOSURE METERS;

6 SULFATOXIMELATONIN; MELATONIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EXPOSURE VARIABLE; EXTREMELY LOW FREQUENCY MAGNETIC FIELD; FEMALE; HORMONE RELEASE; HORMONE SYNTHESIS; HORMONE URINE LEVEL; HUMAN; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; PINEAL BODY; PRIORITY JOURNAL; SHIFT WORKER; STATISTICAL ANALYSIS; URINALYSIS; WORKER;

EID: 33845270205     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.20254     Document Type: Article

References (34)

1. Akerstedt T, Hume K, Minors D, Waterhouse J. 1998. Experimental separation of time of day and homeostatic influences on sleep. Am J Physiol 274:1162-1168.
2. Aldhous M, Arendt J. 1988. Radioimmunoassay for 6-sulphatoximelatonin in urine using an iodinated tracer. Ann Clin Biochem 25:298-303.
3. Arendt J. 2003. Importance and relevance of melatonin to human biological rhythms. J Neuroendocrinol 15:427-431.
4. Arnetz BB, Berg M. 1996. Melatonin and adrenocorticotropic hormone levels in video display unit workers during work and leisure. J Occup Environ Med 38:1108-1110.
5. Bakos J, Nagy N, Thuroczy G, Szabo LD. 1997. Urinary 6- sulphatoxymelatonin excretion is increased in rats after 24 hours of exposure to vertical 50 Hz, 100 microT magnetic field. Bioelectromagnetics 18(2):190-192.
6. Bakos J, Nagy N, Thuroczy G, Szabo LD. 2002. One week of exposure to 50 Hz, vertical magnetic field does not reduce urinary 6-sulphatoxymelatonin excretion of male wistar rats. Bioelectromagnetics 23(3):245-248.
7. Boscolo P, Bergamaschi A, Di Sciascio MB, Benvenuti F, Reale M, Di Stefano F, Conti P, Di Gioacchino M. 2001. Effects of low frequency electromagnetic fields on expression of lymphocyte subsets and production of cytokines of men and women employed in a museum. Sci Total Environ 270:13-20.
8. Burch JB, Reif JS, Yost MG, Keefe TJ, Pitrat CA. 1998. Nocturnal excretion of a urinary melatonin metabolite among electric utility workers. Scand J Work Environ Health 24:183-189.
9. Burch JB, Reif JS, Noonan CW, Yost MG. 2000. Melatonin metabolite levels in workers exposed to 60-Hz magnetic fields: Work in substations and with 3-phase conductors. J Occup Environ Med 42:136-142.
10. De Bruyn L, de Jager L, kuyl JM. 2001. The influence of long-term exposure of mice to randomly varied power frequency magnetic fields on their nocturnal melatonin secretion patterns. Environ Res 85:114-121.
11. Floderus B, Persson T, Stenlund C. 1996. Magnetic-field exposures in the workplace: Reference distribution and exposures in occupational groups. Int J Occup Environ Health 2:226-238.
12. Gobba F, Borella P, Roccatto L, Giacobazzi PL, Bargellini A. 2002. Natural killer activity in workers exposed to various levels of Extremely Low Frequency-Electromagnetic Fields (ELF-EMF). Int J Immunopathol Pharmacol 15:29.
13. Graham C, Cook M. 1999. Human sleep in 60 Hz magnetic fields. Bioelectromagnetics 20:277-283.
14. Graham C, Cook Mr, Kavet R, Sastre A, Smith DK. 1998. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res 24:230-238.
15. Graham C, Cook MR, Sastre A, Riffle DW, Gerkovich MM. 2000. Multi-night exposure to 60 Hz magnetic fields: Effects on melatonin and its enzymatic metabolite. J Pineal Res 28: 1-8.
16. International Agency For Research On Cancer (IARC). 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 80. Non-ionizing radiation, Part 1: Static and extremely low-frequency (ELF) electric and magnetic fields. Lyon: International Agency for Research on Cancer. Available at the Internet site: http://monographs.iarc.fr/.
17. International Commission For Non Ionizing Radiation Protection (ICNIRP). 2001. Standing Committee on Epidemiology: Review of the Epidemiologic Literature on EMF and Health. Environ Health Perspect 109:911-933.
18. Juutilainen J, Stevens RG, Anderson LE, Hansen NH, Kilpelainen M, Kumlin T, Laitinen JT, Sobel E, Wilson BW. 2000. Nocturnal 6-hydroxymelatonin sulfate excretion in female workers exposed to magnetic fields. J Pineal Res 28:97-104.
19. Kato M, Honma K, Shigemitsu T, Shiga Y. 1994. Horizontal of vertical 50-Hz, 1-microT magnetic fields have no effect on pineal gland or plasma melatonin concetration of albino rat. Neurosci lett 168:201-208.
20. Kaune WT, Guttman JL, Kavet R. 1997. Comparison of coupling of humans to electric and magnetic fields with frequencies between 100 Hz and 100 kHz. Bioelectromagnetics 18: 67-76.
21. Lambrozo J, Touitou Y, Dab W. 1996. Exploring the EMF-melatonin connection: A review of the possible effects of 50-60 Hz electric and magnetic fields on melatonin secretion. Int J Occup Environ Health 2:37-47.
22. Maestroni GJ. 1993. The immunoneuroendocrine role of melatonin. J Pineal Res 14:1-10.
23. Methner MM, Bowman JD. 2000. Hazard surveillance for industrial magnetic fields: I. Walkthrough survey of ambient fields and sources. Ann Occup Hyg 44:603-614.
24. National Radiological Protection Board (NRPB). 2001. Documents of the NRPB. ELF Electromagnetic Fields and the Risk of Cancer. NRPB, Chilton, Didcot, Oxon. Available at the Internet site: http://www.nrpb.org/.
25. Panzer A, Viljoen M. 1997. The validity of melatonin as an oncostatic agent. J Pineal Res 22:184-202.
26. Pfluger DH, Minder CE. 1996. Effects of exposure to 16.7 Hz magnetic fields on urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers. J Pineal Res 21:91-100.
27. Reiter RJ. 1994. Melatonin suppression by static and extremely low frequency electromagnetic fields: Relationship to the reported increased incidence of cancer. Rev Environ Health 10:171-186.
28. Reiter RJ. 2004. Mechanisms of cancer inhibition by melatonin. J Pineal Res 37:213-214.
29. Rogers WR, Reiter RJ, Smith HD, Barlow-Walden L. 1995. Rapid-onset/offset, variably scheduled 60 Hz electric and magnetic field exposure reduces nocturnal serum melatonin concentration in nonhuman primates. Bioelectromagnetics(Suppl 3):119-122.
30. Stevens RG, Davis S. 1996. The melatonin hypothesis: Electric power and breast cancer. Environ Health Perspect 104:135-140.
31. Thompson C, Franey C, Arendt J, Checley SA. 1988. A comparison of melatonin secretion in depressed patients and normal subjects. Br J Psychiatry 152:260-265.
32. Touitou Y. Lambrozo J, Camus F, Charbury H. 2003. Magnetic fields and the melatonin hypothesis: A study of workers chronically exposed to 50-Hz magnetic fields. Am J Physiol Regul Integr Comp Physiol 284:1529-1535.
33. Wertheimer N, Leeper E. 1979. Electrical wiring configuration and childhood cancer. Am J Epidemiol 109:273-284.
34. Wetterberg L, Bergiannaki Jd, Paparrigopoulos T, Von Knorring L, Eberhard G, Bratlid T, Yuwiler A. 1999. Normative melatonin excretion: A multinational study. Psychoneuroendocrinology 24:209-226.